Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

A systems view of epithelial-mesenchymal transition signaling states.

Thomson S, Petti F, Sujka-Kwok I, Mercado P, Bean J, Monaghan M, Seymour SL, Argast GM, Epstein DM, Haley JD.

Clin Exp Metastasis. 2011 Feb;28(2):137-55. doi: 10.1007/s10585-010-9367-3. Epub 2010 Dec 31.

2.

TRAF2 phosphorylation promotes NF-κB-dependent gene expression and inhibits oxidative stress-induced cell death.

Zhang L, Blackwell K, Altaeva A, Shi Z, Habelhah H.

Mol Biol Cell. 2011 Jan 1;22(1):128-40. doi: 10.1091/mbc.E10-06-0556. Epub 2010 Nov 30.

3.

Molecular clustering based on ERα and EIG121 predicts survival in high-grade serous carcinoma of the ovary/peritoneum.

Schlumbrecht MP, Xie SS, Shipley GL, Urbauer DL, Broaddus RR.

Mod Pathol. 2011 Mar;24(3):453-62. doi: 10.1038/modpathol.2010.211. Epub 2010 Nov 19.

4.

[Chemokine and chemokine receptor related to cancer metastasis].

Yanagie H, Hisa T, Ono M, Eriguchi M.

Gan To Kagaku Ryoho. 2010 Nov;37(11):2052-7. Japanese.

PMID:
21084802
5.

Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.

Zhang J, Patel L, Pienta KJ.

Prog Mol Biol Transl Sci. 2010;95:31-53. doi: 10.1016/B978-0-12-385071-3.00003-4. Review.

6.

The novel estrogen-induced gene EIG121 regulates autophagy and promotes cell survival under stress.

Deng L, Feng J, Broaddus RR.

Cell Death Dis. 2010;1:e32. doi: 10.1038/cddis.2010.9.

7.

Epithelial-to-mesenchymal transitions and circulating tumor cells.

Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW, Polette M, Gilles C.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):261-73. doi: 10.1007/s10911-010-9174-0. Epub 2010 May 7. Review.

PMID:
20449641
8.

Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cells.

Zhang T, Ma Z, Wang R, Wang Y, Wang S, Cheng Z, Xu H, Jin X, Li W, Wang X.

Cancer Immunol Immunother. 2010 Jul;59(7):1097-108. doi: 10.1007/s00262-010-0836-y. Epub 2010 Mar 30.

PMID:
20352429
9.

Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor beta signaling cascade.

Mullenders J, Fabius AW, van Dongen MM, Kuiken HJ, Beijersbergen RL, Bernards R.

Mol Cancer Res. 2010 Apr;8(4):592-603. doi: 10.1158/1541-7786.MCR-09-0386. Epub 2010 Mar 23.

10.

Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.

Avgeris M, Mavridis K, Scorilas A.

Biol Chem. 2010 May;391(5):505-11. doi: 10.1515/BC.2010.056. Review.

PMID:
20302518
11.

The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets.

Bambace NM, Levis JE, Holmes CE.

Platelets. 2010;21(2):85-93. doi: 10.3109/09537100903470298.

PMID:
20063989
12.

The cytoplasmic adaptor protein X11alpha and extracellular matrix protein Reelin regulate ApoE receptor 2 trafficking and cell movement.

Minami SS, Sung YM, Dumanis SB, Chi SH, Burns MP, Ann EJ, Suzuki T, Turner RS, Park HS, Pak DT, Rebeck GW, Hoe HS.

FASEB J. 2010 Jan;24(1):58-69. doi: 10.1096/fj.09-138123. Epub 2009 Aug 31.

13.

Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2).

White-Adams TC, Berny MA, Tucker EI, Gertz JM, Gailani D, Urbanus RT, de Groot PG, Gruber A, McCarty OJ.

Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1602-7. doi: 10.1161/ATVBAHA.109.187393. Epub 2009 Aug 6.

14.

Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models.

Jain S, Russell S, Ware J.

J Thromb Haemost. 2009 Oct;7(10):1713-7. doi: 10.1111/j.1538-7836.2009.03559.x. Epub 2009 Jul 17.

15.

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.

Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S.

Breast Cancer Res. 2009;11(4):R46. doi: 10.1186/bcr2333. Epub 2009 Jul 9.

16.

Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis.

Holmes CE, Levis JE, Ornstein DL.

Clin Exp Metastasis. 2009;26(7):653-61. doi: 10.1007/s10585-009-9264-9. Epub 2009 May 15.

PMID:
19444623
17.

Malignancies and catastrophic anti-phospholipid syndrome.

Miesbach W.

Clin Rev Allergy Immunol. 2009 Jun;36(2-3):91-7. doi: 10.1007/s12016-008-8101-2. Review.

PMID:
19048416
18.

Revisiting the biological roles of PAI2 (SERPINB2) in cancer.

Croucher DR, Saunders DN, Lobov S, Ranson M.

Nat Rev Cancer. 2008 Jul;8(7):535-45. doi: 10.1038/nrc2400. Epub 2008 Jun 12. Review.

PMID:
18548086
19.

Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2.

White TC, Berny MA, Tucker EI, Urbanus RT, de Groot PG, Fernández JA, Griffin JH, Gruber A, McCarty OJ.

J Thromb Haemost. 2008 Jun;6(6):995-1002. doi: 10.1111/j.1538-7836.2008.02979.x.

20.

Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'.

Urbanus RT, Pennings MT, Derksen RH, de Groot PG.

J Thromb Haemost. 2008 Aug;6(8):1405-12. doi: 10.1111/j.1538-7836.2008.03021.x. Epub 2008 May 15.

Supplemental Content

Support Center